# Clopidogrel

## Clopidogrel 75mg

| 藥物代碼 | OCLOPD |
| :--- | :--- |
| 適應症 | Prevention of atherothrombotic events in patients suffering from MI, ischemic stroke or established peripheral arterial disease; in patients suffering from non-ST segment elevation acute coronary syndrome \(unstable angina or non-Q-wave MI\) in combination with aspirin. ST segment elevation acute MI in combination with aspirin in patients eligible for thrombolytic therapy. |
| 副作用 | GI bleeding, purpura, bruising, haematoma, epistaxis, haematuria, ocular haemorrhage, intracranial bleeding, abdominal pain, dyspepsia, gastritis & diarrhoea, rash, pruritus.Cardiovascular: Chest pain, Hypertension \(4.3% \)Dermatologic: Pruritus \(3.3% \), Purpuric disorder \(5.3% \), Rash \(4.2% \)Endocrine metabolic: HypercholesterolemiaGastrointestinal: Abdominal pain, Constipation, Diarrhea, Gastritis, IndigestionHematologic: Epistaxis \(2.9% \), Purpura \(5.3% \)Musculoskeletal: Arthralgia \(6.3% \), Backache \(5.8% \)Neurologic: Headache \(7.6% \) |
| 禁忌 | Severe liver impairment. Peptic ulcer & intracranial haemorrhage. Lactation. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult & elderly 75 mg once daily. Patients with non-ST segment elevation acute coronary syndrome Initially 300 mg as single loading dose & then continued at 75 mg once daily \(with 75-325 mg aspirin daily\). Recommended dose of aspirin should not be &gt;100 mg. ST segment elevation acute MI Initially 75 mg daily as single loading dose in combination with aspirin & with or without thrombolytics. |
| 肝功能異常 | 無需調整劑量  1.使用於可能有出血體質的中度肝功能不良患者之經驗有限，應小心使用於此病人群。 2.藥物基因學：肝臟酵素CYP2C19 代謝功能不佳病人會降低clopidogrel 之抗血小板反應，雖然提高clopidogrel 劑量會增強CYP2C19 代謝功能不佳病人之抗血小板反應，惟CYP2C19 代謝功能不佳病人之適當給藥劑量尚未完全建立。 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

